drugset

drugset / Trial / NCT01225991

Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis

NCT01225991 ↗

Phase 4 Completed 18 enrolled University of California, Los Angeles Forest Laboratories · collab

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effects of milnacipran for the treatment of pain in rheumatoid arthritis in older adults.

Timeline

Start: 2010-11
Primary completion: 2013-05
Completion: 2013-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Milnacipran	Other / unclassified	100 mg	—

Indications